Champions Oncology, Inc. (CSBR)
Oxford Ledge is still expanding full research coverage of CSBR. A live quote, fundamentals, and analysis are available in the app; the SEC-sourced material below is what we currently have indexed here.
Business summary
A research platform company provides drug discovery and development services using proprietary tumor models and datasets to biopharmaceutical clients.
SEC filings
- 8-K Departure/election of directors or officers; Financial statements and exhibits 2026-03-30
- 10-Q Quarterly financial report (unaudited) 2026-03-12
- 8-K Results of operations / financial condition; Financial statements and exhibits 2026-03-12
- 10-Q Quarterly financial report (unaudited) 2025-12-15
- 8-K Results of operations / financial condition; Financial statements and exhibits 2025-12-15
Source: SEC EDGAR.
Insider activity
5 recent insider (SEC Form 4) filings on record for CSBR. View the transactions in the terminal.
Source: SEC EDGAR (Form 4).
- Open CSBR in the Oxford Ledge terminal — live quote, chart, and analysis in the app.
- Browse the covered-stock index
- Learn to analyze stocks yourself
The material above is drawn from public SEC EDGAR filings and is provided for educational purposes, not as investment advice. Live pricing and fundamentals are available in the terminal.